The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase.EBI
The University Of Montana
N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.EBI
University Of Ljubljana
Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction.EBI
University Institute Of Pharmaceutical Sciences
Discovery of Selective Inhibitors Targeting Acetylcholinesterase 1 from Disease-Transmitting Mosquitoes.EBI
Ume£
Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.EBI
University Of Ljubljana
Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors.EBI
Kyung Hee University
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.EBI
University Of Ljubljana
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.EBI
Kyung Hee University
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.EBI
Ume£
Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides.EBI
Fudan University
A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.EBI
University Of Missouri St. Louis
Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease.EBI
Csir-Central Drug Research Institute
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.EBI
Universit£
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.EBI
Fudan University
Fragment-based drug discovery.EBI
Sunesis Pharmaceuticals
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.EBI
Eisai
Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine.EBI
University Of South Carolina
Activation of the endocannabinoid system by organophosphorus nerve agents.EBI
University Of California
Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.EBI
Kyoto University
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.EBI
Kyoto University
 
Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compoundsEBI
TBA
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacology.EBI
Warner-Lambert
Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates.EBI
Pfizer
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.EBI
Eisai
A FLT3-inhibitory constituent from the rhizomes of Anemarrhena asphodeloides.BDB
Gyeongsang National University
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.BDB
Wyeth Research